Evidence map›Paper›PMID 19731080›Full record

ArticleFamilial cancer2010

Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis.

Kory W Jasperson, Thuy M Vu, Angela L Schwab, Deborah W Neklason, Miguel A Rodriguez-Bigas, Randall W Burt, Jeffrey N Weitzel

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Familial cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023
    Guideline
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Cost-effectiveness of population-wide genomic screening for Lynch syndrome in the United States.Genetics in medicine : official journal of the American College of Medical Genetics · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2010
    Article
  16. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Kory W JaspersonCancer Screening & Prevention Program, City of Hope Cancer Center, Duarte, CA, USA. kory.jasperson@hci.utah.edu
Thuy M Vu
Angela L Schwab
Deborah W Neklason
Miguel A Rodriguez-Bigas
Randall W Burt
Jeffrey N Weitzel
University of Utah · USCity of Hope · USCancer Genetics (United States) · USThe University of Texas MD Anderson Cancer Center · US

Funding

ZOPOLRESTAT IN NORMOTENSIVE, TYPE 1 DIA WITH INCIPIENT NEPHROPATHYM01RR000043 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZAIA, JOHN A · 1985 to 2010
$76.4M
CLINICAL CANCER GENETICS FELLOWSHIP PROGRAMR25CA085771 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI WEITZEL, JEFFREY N · 2001 to 2010
$3.8M
Clinical Cancer Genetics Community Network: A Sustainable Research PartnershipRC4CA153828 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WEITZEL, JEFFREY N · 2010 to 2010
$1.0M
NCI NIH HHS R25 CA085771NCI NIH HHS R25 CA85771NCI NIH HHS RC4 CA153828NCRR NIH HHS M01 RR000043NCRR NIH HHS M01RR000043
6 · The paper itself

Abstract

To characterize the frequency of germline mutations associated with Lynch syndrome and review the potential expanded differential diagnoses in very early onset colorectal cancer (CRC) cases without apparent polyposis. Retrospectively reviewed medical records of 96 probands with CRC diagnosed prior to age 36 from three cancer centers. Determined the frequency of germline mutations in probands meeting different clinical criteria used to identify Lynch syndrome. Three of 46 (6.5%) single case indicators (probands without additional personal or family history suspicious for Lynch syndrome) were identified to carry a deleterious or suspected deleterious mismatch repair (MMR) mutation compared with 10 of 19 (52.6%) in the cases meeting at least one additional revised Bethesda guideline, and 11 of 15 (73.3%) in the cases meeting Amsterdam criteria. Two families without MMR mutations were documented to have a germline APC or TP53 mutation after additional clinical features were identified. Our results suggest that single cases of CRC (those without additional personal or family history suspicious of Lynch syndrome) diagnosed prior to age 36 infrequently have identifiable MMR mutations, especially when compared to cases meeting additional criteria. Careful attention to evolving or additional clinical features is warranted and may lead to an alternate genetic diagnosis in families with early onset CRC.

Indexed as

Adenomatous Polyposis ColiAdolescentAdultCohort StudiesColorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisDiagnosis, DifferentialDNA Mismatch RepairFemaleGenetic Predisposition to DiseaseGerm-Line MutationHumansMalePedigreeRetrospective StudiesYoung Adult

Identifiers

PMID19731080
PMCPMC3620042
OpenAlexW1983241847

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.